Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context

Article reviews clinical & methodological heterogeneity of studies of IL-6 antagonists, & considers how this might have influenced reported treatment effects. Severity of illness and concomitant corticosteroids are among factors that might have contributed to inconsistent results

Source:

The Lancet Respiratory Medicine